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Evidence for an autologous immune complex pathogenic mecha-
nism in acute poststreptococcal glomerulonephritis. Clinical and
experimental studies have suggested a role for antiimmuno-
globulins in the pathogenesis of glomerulonephritis associated
with streptococcal infection. We attempted to localize anti-IgG
in the kidneys of 22 patients who had renal biopsies performed 7
to 66 days after the onset of acute poststreptococcal glomerulo-
nephritis (APSGN). In addition to routine localization of immu-
noglobulins and C3, specimens were stained with neuraminidase-
treated, heat-aggregated, and unmodified IgG. Twelve biopsies
showed staining with fluorescein-labeled human neuraminidase-
treated IgG. A lesser number gave positive staining with the oth-
er IgG preparations. Following treatment of slides with 0.01 M
citrate buffer, seven previously negative biopsies showed posi-
tive staining with neuraminidase-treated IgG. The demonstration
of anti-IgG by these methods was possible in 19 out of 22
biopsies. It correlated best with the presence of C3 and IgG, and
to a lesser extent with 1gM, in the renal glomerulus. These re-
suits and our previous finding of elevated levels of serum anti-
IgG early in the course of APSGN, and as early as 8 days follow-
ing the antecedent streptococcal infection, support a role for
anti-IgG in the immune pathogenesis of APSGN. Although our
series of studies support the hypothesis that anti-IgG is formed to
an IgG modified enzymatically by streptococcal product, the for-
mation of this autoantibody to IgG incorporated in an exogenous
(streptococcal antigen-antibody) complex can not be ruled out.
Preuve d'un mécanisme pathogénique mettant en jeu les im-
muns complexes autologues dans Ia glomerulonéphrite aiguë post-
streptococcique. Les etudes cliniques et expérimentales ont sug-
géré un role des antiimmunoglobulines dans Ia pathogenie de Ia
glomerulonephrite associée a une infection streptococcique.
Nous avons essayé de localiser l'anti-IgG dans les biopsies ré-
nales de 22 malades, biopsies réalisées 7 a 66jours après le dé-
but d'une glomérulonéphrite post-streptococcique (APSGN). En
plus de Ia localisation habituelle des immunoglobulines et do C3,
les échantillons ont été traités par de l'IgG traitée par Ia neura-
minidase, ou agrégée par Ia chaleur, ou non modifiée. Dans 12
biopsies une fluorescence a été observée pour l'IgG traitée par Ia
neuraminidase. Des images positives pour les autres prépara-
tions dIgG ont été observées dans un moms grand nombre de
biopsies. Sept biopsies initialement negatives pour l'IgG traitée
par Ia neuraminidase sont devenues positives aprCs traitement
par un tampon citrate 0,01 M. La mise en evidence de l'anti-IgG
par ces méthodes a été possible pour 19 biopsies sur 22. Cette
presence est bien correlée avec celle de C3 et d'IgG et a moindre
degre d'IgM. Ces résultats, ainsi que notre constation antérieure
de concentrations sériques élevées d'anti-IgG précocément au
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cours de l'APSGN—dès le 8ème jour de l'infection streptococ-
cique—sont en faveur du role de l'anti-IgG dans Ia pathogénie
immune de I'APSGN. Quoique notre étude soit en faveur de
l'hypothése selon laquelle l'anti-IgG a partir d'une IgG modifiée
par le produit streptococcique, la formation de cet auto-anticorps
contre de l'IgG incorporé dans un complexe exogéne (anticorps-
antigène streptococcique) ne peut pas être exclue.
The renal injury following infection with neph-
ritogenic streptococcus is generally considered to
have an immune-complex pathogenesis [1—4]. There
is, however, considerable controversy as to the na-
ture of the antigen(s) involved and the character-
istics of the antigen-antibody interaction [1].
The finding of cryoglobulins in the sera of these
patients, and particularly, the demonstration of sia-
lic acid depletion of the IgG component of these
cryoproteins, led to the postulation that such altera-
tion in the structure could account for an antigenic
transformation of autologous IgG [5—7]. Demonstra-
tion in rabbits of the nephritogenic potential of au-
tolgous IgG thus modified by streptococcus and,
more specifically, by neuraminidase, suggested a
possible determinant role for this material in the
pathogenesis of acute poststreptococcal glomerulo-
nephritis (APSGN) [8,9]: antiglobulin response to
altered IgG could result in the formation of circulat-
ing or glomerular-fixed immune complexes.
Recently, we have demonstrated anti-IgG in the
serum of the majority of the patients with APSGN,
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and found that these autoantibodies appear very
early in the course of the disease [10—111. The pur-
pose of this communication is to report the in-
cidence and nature of antiglobulins in the glomeru-
lus of patients with acute poststreptococcal glomer-
ulonephritis.
Methods
Twenty-two patients (12 males and 10 females)
are the subject of this study. The age of the patients
ranged between 2 and 18 yr; only one patient was
older than 11 yr of age. There was evidence of a
preceding streptococcal infection in all patients as
shown by elevated antistreptolysin 0 and anti-
hyaluronidase titers and streptozyme test. Skin in-
fection anteceded nephritis in 16 patients, pharyn-
geal infection in three, and both skin and throat in-
fections in three patients. The time of onset of
streptococcal infection and the time of the first sign
or symptom of nephritis were recorded. All patients
were admitted to the Hospital Universitario de
Maracaibo, Venezuela, with an acute nephritic syn-
drome (hematuria, urinary red cell casts, hyper-
tension, and edema). After clinical and serologic
studies were done, percutaneous renal biopsy was
obtained following informed consent. In addition to
clinical and laboratory evaluation of renal disease,
titers of antistreptolysin 0 (Hyland Laboratories re-
agent kit), antihyaluronidase (Bacto-Difco Reagent
Kit), and streptozyme (Wampole rapid slide test)
were measured. Serum levels of IgG, 1gM, IgA, and
C3 were quantitated by immunodiffusion. Circulat-
ing immune complexes were measured by the Clq
binding assay of Zubler, Nydegger, and Perrin [12]
with Clq labeled iodine 125 (12I) and polyethylene
glycol. The method of Clq determination has been
detailed in a previous communication (RoDRIGuEz-
ITURBE et al: Submitted for publication). Clq was
isolated from normal human serum radiolabeled with
125J and reacted with the test sera. Separation of free
from complex bound '251-Clq was achieved by se-
lective precipitation with polyethylene glycol. CIq
binding activity (C1qBA) was calculated as the per-
cent of 1251-Clq precipitated. All samples were test-
ed in duplicate. Serum samples from apparently
normal healthy individuals were included on each
test run. The procedure was also performed react-
ing '251-Clq with varying amounts of aggregated IgG
(aggregated by heat and precipitation with sodium
sulfate). CIqBA was measured in over 100 apparent-
ly healthy subjects. The mean binding obtained was
9.5 2.6. Therefore, the mean + 2 SD was 14.7,
and in our laboratories Clq greater than 15% is con-
sidered abnormal. Rheumatoid factor was deter-
mined by agglutination using latex particles coated
with IgG and by immunoabsorbent using IgG
coupled to CNBR activated sepharose [10, 11].
The serologic studies were performed on 119 pa-
tients admitted to the hospital with well-docu-
mented APSGN [10,11]. The 22 patients reported
here were selected from the total group and repre-
sent those patients from whom renal tissue was
available for study.
Renal biopsy studies. A portion of the renal
biopsy specimen was fixed in 10% buffered formalin
and 4- paraffin sections stained with hematoxylin
and eosin (H&E) and periodic acid Schiff reagent
(PAS) for light microscopy. A part of the tissue was
fixed in gluteraldehyde for electron microscopy.
The remainder of the specimen was snap-frozen in
dry ice and acetone and stored at —70° C for immu-
nohistologic studies. Immunofluorescent studies
were performed on 4-es cryostat sections with fiuo-
rescein isothyocyanate (FITC)-conjugated rabbit
antisera to human IgG (RAH IgG), 1gM (RAH
1gM), and C3 (RAH C3). In addition, unmodified
human IgG (HIgG-u) aggregated human IgG (HIgG-
agg) and neuraminidase-treated (sialic-acid-deplet-
ed) human IgG (HIgG-N) were conjugated with
FITC and used to stain the frozen section by con-
ventional direct immunofluorescent staining meth-
odology. FITC-conjugated unmodified rabbit IgG
(RIgG-u) and FITC rabbit aggregated (RIgG-agg)
were also used for staining purposes.
In all specimens in which fluorescent deposits of
IgG preparations were not observed, the sections
were treated with 0.01 M citrate buffer (pH, 3.2) for
1, 4, and 12 hr at 26° C. The immunofluorescent
staining was then repeated. Renal biopsy specimens
from 97 patients with a variety of renal diseases (see
Table 5) were studied by the same immuno-
histologic methods using the identical antisera.
The methodology used for immunohistologic ob-
servations has been described previously [13—16].
Preparation of human IgG reagents (HIgG). Im-
munoglobulin G (IgG) was isolated from the serum.
of healthy United States males by precipitation with
ammonium sulfate, ion exchange chromatography
on diethylaminoethyl cellulose (DEAE), and Seph-
adex G-200 gel filtration chromatography. The
serum donors had no history of recent illness, no
antibodies to streptococcal enzymes (streptolysin
0, hyaluronidase, streptozyme), and they had nor-
mal urine analyses and endogenous creatinine clear-
ances. Donors' serum levels of C3 and immuno-
globulins (G, M, and A) were normal, and no Clq
binding activity was detected in the serum. Rheu-
matoid factor was not detected in their sera.
The IgG preparation was characterized by immu-
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noelectrophoresis, Ouchterlony double diffusion in
agar gel, and cellulose acetate electrophoresis. No
other serum proteins were detected in the material.
Part of the IgG solution was conjugated with
FITC, and a final concentration of 20 mg/ml was
used for immunohistochemical studies. Part of the
IgG was treated with neuraminidase as described
previously [9] and neuraminidase-treated IgG
(HIgG-N) purified by ammonium sulfate precipi-
tation and gel chromatography using Sephadex G
200 [9]. No neuraminidase was detected in the prep-
aration. The HIgG-N was conjugated with FITC,
and a concentration of 20 mglml was used for immu-
nofluorescent studies.
Immuoglobulin U was aggregated by heating at
63° C for 20 mm followed by precipitation with so-
dium sulfate. The aggregated IgG was separated by
chromatography on Sephadex G-200 and Sepharose
6B. Only the fraction in the exclusion volume of
Sephadex G-200 was used. This fraction appeared
as a single peak on Sepharose. The IgG was con-
jugated with FITC, and a concentration of 20 mg/mI
of the material (HIgG-agg) was used for fluorescent
studies.
Preparation of rabbit IgG reagents (RJgG). Fluo-
rescein-conjugated unmodified rabbit IgG (RIgG-u)
and fluorescein-conjugated rabbit aggregated IgG
(RIgG-agg) were prepared in a manner similar to
that described for the human IgG counterparts. No
antibodies to human serum proteins or streptococ-
cal enzymes were detected in the rabbit serum.
Results
The serologic data on the 119 patients from whom
the cases in this study were selected are the subject
of separate communications [10,11,17] and are sum-
marized in Table 1. All 22 patients in the study had
markedly elevated levels of serum IgG and 1gM.
Serum IgA levels were elevated in six patients. The
C3 levels were depressed in all patients, and Clq
binding activity was elevated in 10 cases. Rheuma-
toid factor titers were elevated in all patients (Table
2).
Renal morphology showed acute, diffuse, prolif-
erative glomerulonephritis in all patients. No altera-
Total
Serologic
findings
No. of
patients
Percent
positive
no. of
patients
studied
Antistreptococcal ABa 81 98.8 82
f IgG (> 1600 mgIlOO ml) 68 93.2 73
IgM(> lSOmg/lOOmI) 77 98.7 78
IgA (> 300 mg/100 ml) 21 26.9 78
C3 (< 100 mgIlOO ml) 65 85.5 76
t CIqBA" (> 15%) 45 55.5 80
Rheumatoidfactor(> 1:32) 106 89.2 119
Table 2. Serological data on the 22 patients in the study'
Patient
No. C3 RF CIqBA ASO AH SZ
Site of
infection
Days from
infection
Days from
nephritis
122 50 1:2048 7.65 170 1024 1:400 5 25 12
128 85 1:128 14.85 340 256 1:400 T 28 U
131 75 1:64 35.59 680 2048 1:400 5 36 6
134 90 1:4096 6.8 280 1024 1:200 5 30 23
135 40 1:1024 27.81 340 > 2048 1:600 T,S 20 8
139 50 1:1024 8.0 340 1024 1:200 T,S 30 10
141 <10 1:256 20.01 280 256 1:600 S 21 7
150 <10 1:4096 34.1 340 2048 1:200 5 14 1
155 50 1:16 6.8 680 2048 1:500 T 21 19
157 54 1:128 11.1 340 1024 1:200 5 U 8
158 70 1:1024 29.3 340 1024 1:400 5 30 19
160 30 1:512 28.5 680 1024 1:600 5 28 15
162 30 1:128 8.4 960 2048 1:400 T 14 10
164 40 1:512 21.6 680 2048 1:800 5 21 14
165 50 1:64 16.6 960 2048 1:800 T 11 5
166 55 1:1024 21.6 340 2048 1:400 5 U U
167 54 1:512 12.5 340 1024 1:800 T,S 27 9
169 56 1:64 6.06 480 512 1:400 5 26 15
170 60 1:1024 6.9 480 2048 1:200 S 24 8
171 50 1:64 19.4 240 512 1:200 5 19 8
174 75 1:256 5.1 480 1024 1:800 5 30 18
175 35 1:64 11.98 480 1024 1:400 5 13 7
a C3, rheumatoid factor (RF), Clq binding (CIqBA), antistreptolysin 0 (ASO), antihyaluronidase (AH), and streptozyme (SZ), were
performed at the time of admission to the hospital. Site of infection is: S. skin; T, throat. Days from onset of infection by history and
onset of clinical signs of nephritis represent the interval between these times and obtaining serological data. U is unknown.
Table 1. Summary of serologic findings in acute poststreptoccal
glomerulonephritis
a Evidence of streptococcal infection was indicated by the fol-
lowing: streptozyme 1:100; antistreptolysin 0> 1:125 Todd units
for patients under 5 yr of age, and > 1:250 Todd units for pa-
tients aged 5 yr and older; antihyaluronidase > 1:125; or com-
bination.
b CIqBA = Clq-binding activity.
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tions suggestive of chronicity were observed. The
results of immunohistologic studies are shown in
Table 3. The interval of time that elapsed from the
biopsy to the first sign or symptom of infection and
nephritis is also noted in Table 3.
There was no relationship between the immuno-
histologic results and the site of infection, age, sex,
apparent duration of nephritis, or time elapsed from
streptococcal infection. All biopsies had positive
stainings with antihuman C3. Twenty biopsies had
positive staining for IgG, and 15 were positive for
1gM. Twelve biopsies had positive staining with
HIgG-N. All the patients showing positive staining
with HIgG-N or HIgG-agg, also showed similar flu-
orescent deposits of IgG and C3.
Immunoglobulin M deposits were demonstrated
in 9 of 12 patients with positive HIgG-N staining.
On the other hand, all biopsies but one, showing
glomerular 1gM deposition, showed HIgG-N-posi-
tive staining. Unmodified human IgG fixed in the
glomeruli of nine biopsies; all of them had HIgG-N-
positive staining. Only one patient showed positive
HIgG-N staining and negative results with HIgG-u
and HIgG-agg.
Of those biopsies that presented positive stain-
ing with HIgG-N, seven were also positive with
RIgG-u.
In general, staining with HIgG-N was the most
prominent, staining with HIgG-u was somewhat
less, and the staining with HIgG-agg was more com-
monly focal, segmental, and weaker. Figs. 1—6
shows immunohistologic staining of representative
glomeruli from patient #171.
Following treatment of the negative biopsy speci-
mens with citrate buffer, 1gM and IgG were not lo-
calized in those patients in whom these immuno-
globulins were not detected by direct immuno-
fluorescence prior to elution. However, After a 12-
hr elution period, it was possible to show HIgG-N
fixed in the glomeruli of seven out of nine patients
that were previously negative. The same was true
for six out of nine patients with respect to HIgG-u.
The results of the acid elution experiments are
shown in Table 4. A variety of immunohistologic
patterns were observed: fine granular capillary
walls, fine or coarse, granular, mesangial, or combi-
nations. In general, deposits with all fluorescent
reagents showed similar patterns in the same pa-
tient. The results of immunohistologic studies on
controls are shown in Table 5.
Table 3. Immunohistologic data
Patient
no.
Time from
nephritis
days
Time from
infeetio&'
days
lmmunohistology with FITCconjugatedc
RAHIgG RAHIgM RAHC3 HIgG(N) HIgG(agg) HIgG(u) RIgG(agg) RIgG(u)
122 36 NK + + + — — —
128 23 53 + — + — — — — —
131 24 44 + + + — — ND — —
134 23 30 + — + — — ND — —
135 66 36 + + + + + + + +
139 7 21 + — + + + -- + +
141 32 53 + + + + + + + -I-
150 9 39 — — + — — — —
155 31 60 + — + — — — —
157 15 22 + + + + + + — —
158 19 30 -4- + + — — —
160 15 18 + + + + + + + +
162 13 14 + -I- + — — — — —
164 14 21 — + + — — —
165 11 17 + + + — — ND —
166 NK NK + + + ND ND ND -
167 9 27 + — + + + ND ND ND
169 15 26 + + + + + + ND ND
170 8 24 + + + + + + ND -4-
171 8 19 + + + + + + + +
174 18 30 + + + + ND ND ND ND
175 7 13 + + + + + + + +
Interval of time is between onset of nephritis and renal biopsy.
Interval of time is between onset of streptococcal infection and biopsy.
Symbols are +,positive; —, negative. Abbreviations are: NK, not known, ND, not done; RAHTgG, rabbit antihuman lgG; RAHIgM,
rabbit antihuman 1gM; RAHC3, rabbit antihuman C3; HIgG(N), neuraminidase-treated human IgU; HIgG(agg), aggregated human IgG;
HIgG(u), unmodified human Igo; RIgG(agg), aggregated rabbit IgG; RIgG(u), unmodified rabbit IgU.
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Fig. 1. Fluorescein isoihiocyanate (FITC)-conjugated rabbit antisera to human IgG, showing
granular deposits along glomerular capillary walls and in the mesangium <32O).
Discussion
The latent period between streptococcal infection
and the development of nephritis has long suggested
a sequence of events similar to that of serum sick-
ness in the experimental animal [1—4]. Immuno-
histologic demonstration of granular deposits of im-
munoglobulins and complement components in the
glomerulus, and the demonstration of electron-
dense subepithelial deposits representing immuno-
globulins and complement, as well as the depres-
sion of serum complement early in the disease, fur-
ther support an immune-complex pathogenesis [1,
2, 4]. In addition, there is a more direct evidence in
favor of the circulating immune complex hypothesis
since cryoprecipitable and Clq-binding immune
complexes have been shown to be present in the
serum of patients with APSGN [7] (RoDRIGuEz-
ITURI3E et a!, submitted for publication).
The nature of the association between strepto-
coccal infection and nephritis led to early specula-
tion that an exogenous antigen, related to strepto-
coccus, was involved in the formation of pathogenic
immune complexes. Several investigators, how-
ever, have attempted to localize soluble streptococ-
cal antigens in the glomeruli of patients with
APSGN, but the results have been negative, diffi-
cult to repeat, or inconclusive [1, 18—20]. Treser et
al have detected streptococcal antigenic material,
distinct from M protein, in the glomeruli of early
biopsy tissue from patients with APSGN [19, 20].
These investigators stress the importance of the
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Fig. 2. Gloinerulus stained wit/i FITC—conjugated rabbit antisera
to human 1gM showing granular deposits along the glomerular
basement membrane and in the mesangium (same patient #171);
(x282).
presence of this material in biopsies obtained early
in the course of APSGN, suggesting that later in the
disease the antigenic sites are saturated with excess
antibody. Antibodies against this water-soluble an-
tigen fraction (endostreptosin) have been detected
in the sera of patients with acute poststreptococcal
glomerulonephritis [211. Elevated titers, however,
are also present after uncomplicated streptococcal
infections. Villarreal and Zabriskie have recently ob-
served an extracellular protein unique to nephrito-
genic streptococci [221. It is noteworthy that none
of the streptococcal antigens implicated have been
identified in the subepithelial electron-dense depos-
its or "humps" that are so characteristic of the dis-
ease [17, 231.
We have reported the detection of serum cryo-
globulins with biologic properties of immune com-
plexes in all patients studied during the acute phase
of APSGN [7]. Streptococcal immunoreactive ma-
terial could only occasionally be found as a constit-
uent of these cryoproteins by a variety of immuno-
logical techniques [5—7]. Moreover, streptococcal
antigen and antibody were never detected simulta-
neously in cryoprecipitates isolated from patients
with this disease [5—7]. The finding of anti-IgG ac-
tivity in some of the cryoprecipitates led to the sug-
gestion of a role for an autologous immune-complex
mechanism in nephritis related to streptococcal in-
fection [6]. In this postulated mechanism, anti-
bodies produced to IgG rendered autoimmunogenic
by interaction with or modification by a streptococ-
cal product or by incorporation into immune com-
plexes, led to the formation of (anti-IgG) (IgG) path-
ogenic immune complexes. These autoantibodies
could react with the neoantigen in the circulation in
situ in the renal glomerulus. In addition, the autoan-
tibody may also partially react with native host IgG.
In a previous communication, we have reported
the isolation of an 1gM anti-IgG cryoprotein in
which the IgG fraction lacked sialic acid [6]. Zinne-
man, Levi, and Seal isolated a similar cryoglobulin
from a patient with essential cryoglobulinemia and
showed that the 1gM fraction reacted with neura-
minidase-treated (sialic-acid-depleted) IgG, where-
as only a very weak reaction was observed with un-
modified IgG [24]. We have shown that the sialic
acid content of IgG was markedly decreased by in-
cubation with a culture of nephritogenic strepto-
coccus [25]. Autologous IgG modified either by in-
cubation with this microorganism or by treatment
with neuraminidase was capable of inducing
cryoglobulinemia, anti-IgG antibodies, and glomer-
ulonephritis characterized by granular deposition of
IgG and C3 [8, 9]. These events occurred in the ab-
sence of streptococcal infection, elevation of anti-
streptolysin 0 titer, or deposits of streptococcal
material in the glomerulus. Other investigators have
demonstrated the production of monoclonal cryo-
globulins with anti-IgG activity in rabbits following
immunization with streptococcal vaccines [261. Pre-
liminary studies by Davis, Baig, and Ayoub have
shown that certain strains of streptococcus produce
neuraminidase [27].
We have observed elevated titers of anti-IgG ac-
tivity as early as 10 days following the onset of
streptococcal infection and on the day of onset of
symptoms of nephritis in patients with APSGN [10,
11]. These studies suggest that the production of
antiglobulins in APSGN may be related to the
streptococcal infection and may be a primary event
in APSGN. It is possible, however, that the anti-
IgG is an antibody to IgG incorporated in an exoge-
nous immune complex of streptococcal-related anti-
gen and specific antibody.
The fixation of neuraminidase-treated IgG to the
glomerulus of patients in this study supports an au-
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Fig. 3. Glomerulus stained with FITC-conjugated rabbit antisera to human C3 showing fine
granular deposits in the rnesangium and along the capillary basement membranes (same
patient #171); (x320).
tologous immune mechanism in this disease. Reac-
tivity was also observed with unmodified IgG and
aggregated IgG; the fluorescence with these latter
reagents, however, was much less prominent. In
previous studies, we have shown partial immuno-
logic cross-reactivity between unmodified IgG and
neuraminidase-treated IgG [9].
Elution studies permitted the demonstration of
anti-IgG activity in previously negative biopsies.
These studies suggest that, in some patients, com-
plete saturation of antigen with antibody is taking
place.
The hypothesis that antiglobulins are produced in
response to a neoautoimmunogen resulting from the
action of a streptococcal neuraminidase-like en-
zyme, is not unattractive. Anti-IgG antibodies have
been found in the glomeruli of some patients with
nephritis, and it has been suggested that their pres-
ence can exacerbate immune-complex renal disease
[281. In addition, immunoglobulin complexes (IgG-
1gM, IgG-IgG) have been implicated in the patho-
genesis of the renal lesion in systemic lupus ery-
thematosus [29], progressive systemic sclerosis
[301, and essential cryoglobulinemia [32]. It is of in-
terest that ultrastructural studies of glomeruli of
some patients with IgM-anti-IgG cryoglobulinemia
have revealed subepithelial "humps" indistinguish-
able from those observed in APSGN [311.
In our laboratories, we have looked routinely for
antiglobulins in renal biopsy specimens. Excluding
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Fig. 4. Glomerulus stained with FITC-conjugated neuramini-
dase-treated human IgG showing predominant deposits along
the capillary walls and in the mesangium similar to antihuman
Igs and C3 (same patient #171); (x282).
Fig. 6. Glomerulus stained with FITC-conjugated human aggre-
gated IgG showing large but more sparse deposits pre-
dominantly in the mesangium and to a lesser extent along the
glomerular basement membrane (same patient #171); (x282).
a few cases of the nephritis of systemic lupus ery-
thematosus, we have failed to detect these autoanti-
bodies.
It is quite possible that the immune injury in
APSGN involves a variety of exogenous and endog-
Fig. 5. Glomerulus stained with FITC-conjugated untreated rab-
bit igG showing large granular deposits in the mesangium and
along the capillary loops (same patient #17/); (x282).
Table 4. Immunohistologic findings after citrate buffer elution of
biopsies that untreated failed to stain with neuraminidase-treated
human IgG.
.Patient
no.
Immunohistology
---
FITC-HIgG(N)
after 12 hr of acid elutiona
-----
FITC-HlgU(u)
128 — —
131 + —
134 + -
150 + +
155 + +
58 + +
162 + +
164 — —
165 + +
a Symbols arc: +, positive; —, negative. (All specimens where
negative were untreated or treated with citrate buffer for I to 4
hr). FITC-1-IIgG(N) is fluorescein isothyocyanate-corijugated
neuraminidase-treated human TgG. FITC-FTIgG(u) is fluorescein
isothyocyanate-conjugated unmodified human lgG.
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Table 5. Immunohistologic studies on controls
Classification
No. of
Patients
Anti-HIgG
no. positive
Anti-HIgM
no. positive
Anti-HC3
no. positive
HIgG (n)
no. positive
HIgG (u)
no. positive
HIgG(a)
no. positive
Idiopathic membranous nephropathy 7 7 7 7 0 0 0
Proliferative nephritis
Mesangial 7 2 2 4 0 0 0
Focal 9 5 5 7 0 0 0
Diffuse 24 19 13 23 0 0 0
Lupusnephritis 18 15 12 16 0 0 3
Minimal change nephrosis 8 1 2 3 0 0 0
Focal schlerosis 8 3 3 5 0 0 0
Amyloid 3 1 1 1 0 0 0
Diabetic nephropathy 2 2 1 3 0 0 0
Interstitial nephritis 3 2 2 2 0 0 0
Membranous nephropathy
associated with rheumatoid
arthritis and gold therapy 6 5 5 5 0 0 2
Cryoglobulinemia 2 2 2 2 0 0 1
enous immune-complex systems. Such a situation is
observed in the nephritis of systemic lupus ery-
thematosus, where circulating as well as glomeru-
lar-fixed antigen-antibody interactions have been
implicated.
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